作者：
Thierry,Facon [1]
;
Philippe,Moreau [2]
;
Thomas G,Martin [3]
;
Ivan,Spicka [4]
;
Albert,Oriol [5]
;
Youngil,Koh [6]
;
Andrew,Lim [7]
;
Gabor,Mikala [8]
;
Laura,Rosiñol [9]
;
Münci,Yağci [10]
;
Michele,Cavo [11]
;
Kwee,Yong [12]
;
Marie-Laure,Risse [13]
;
Gaëlle,Asset [14]
;
Sandrine,Schwab [14]
;
Gracia,Martinez [15]
作者单位：
Department of Haematology, Lille University Hospital, Lille, France.
[1]
University of Nantes, Nantes, France.
[2]
University of California San Francisco, San Francisco, California, USA.
[3]
Departments of Medicine and Hematology, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic.
[4]
Hematology Department, Institut Català d'Oncologia and Josep Carreras Institute, Hospital Germans Trias i Pujol, Barcelona, Spain.
[5]
Seoul National University Hospital, Seoul, South Korea.
[6]
Austin & Repatriation Medical Center, Heidelberg, Victoria, Australia.
[7]
Department of Hematology and Stem Cell Transplantation, National Institute for Hematology and Infectious Diseases, South Pest Central Hospital, Budapest, Hungary.
[8]
Hospital Clinic, IDIBAPS, Barcelona, Spain.
[9]
Gazi University, Ankara, Turkey.
[10]
IRCCS Azienda Ospedaliero-Universitaria di Bologna, "Seràgnoli" Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
[11]
Department of Haematology, University College Hospital, London, UK.
[12]
Sanofi R&D, Vitry-Sur-Seine, France.
[13]
Sanofi R&D, Chilly-Mazarin, France.
[14]
Hospital das Clínicas de São Paulo, São Paolo, Brazil.
[15]
DOI
10.1002/hon.3038
PMID
35653225
发布时间
2023-04-12
换一批
换一批
